Bioinformatics platforms are extensively utilized for data management and analysis of genomic and proteomic data. These platforms deliver advanced algorithms and statistical tools to analyze vast amounts of biological data, which aids researchers in deriving meaningful insights. The platforms integrate biological and clinical data to accelerate genomic research and expedite drug discovery processes.
The global Bioinformatics Platforms Market is estimated to be valued at US$ 13.15 Mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing generation of extensive genomic data owing to reduced sequencing costs is propelling the demand for effective data analytics tools. Bioinformatics platforms deploy machine learning and artificial intelligence techniques to gain deeper insights from genomic profiles. Their ability to manage massive datasets and draw correlations provides strategic advantages to academic and industrial researchers. As genomic research expands in scale and scope, these platforms are able to efficiently handle big data analytics tasks. Their roles in precision medicine have significantly grown as genomic and clinical data integration is crucial for finding biomarkers and disease targets. Advancements in analytics capabilities are expected to accelerate genomic discoveries and support clinical applications over the forecast period.
Segment Analysis
The global bioinformatics platforms market is segmented into sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms and other platforms. The sequence analysis platforms segment held the largest market share in 2020, as these platforms aid in analyzing sequences of nucleotides or amino acids, which is fundamental requirement for drug discovery and various genomics applications. These platforms help in identifying similarities and differences between biological sequences, which helps researchers gain insight into molecular structure, genetic variations and evolutionary relationships.
Key Takeaways
The Global Bioinformatics Platforms Market Size is expected to witness high growth over the forecast period of 2024 to 2031. The global Bioinformatics Platforms Market is estimated to be valued at US$ 13.15 Mn in 2024 and is expected to exhibit a CAGR of 6.9% over the forecast period 2024 to 2031.
Regional analysis: North America dominated the global market in 2020 and is expected to maintain its dominance over the forecast period. This is attributed to presence of major players and strong infrastructure for biotechnology and life science research in the US and Canada. Moreover, rising investments by pharma and biotech companies in R&D also support market growth.
Key players related content: Key players operating in the bioinformatics platforms market are Canon Inc., Zebra Technologies Corporation, Hewlett-Packard (HP) Inc., Epson America, Inc., BIXOLON. Major players are focusing on new product launches and strategic partnerships to strengthen their business portfolio and market share. For instance, in March 2021, Agilent Technologies Inc. launched its new genetic analysis platform called Agilent Cytogenomics Module 5.1, which supports high-resolution microarrays for karyotyping and molecular analyses.
For more Insights, Read –
https://www.marketwebjournal.com/bioinformatics-platforms-market-market-size-and-share-analysis/
The market for bioinformatics is buoyant, with increasing demand in Asia.Bioinformatics Market Analysis done in the full Report:The Bioinformatics platform offers services that include database design, software engineering and data integration.The sequence analysis is the procedure of subjecting a DNA, RNA or peptide sequence to extensive variety of analytical tools to comprehend its features, function, structure, or evolution.
The Bioinformatics platform is anticipated to grow at a CAGR of 19.9% and will reach revenue of $10.91 billion by 2023.The next product is Knowledge Management tool, which delivers strategy, process and technology.This helps influencing information and knowledge that will escalate the level of understanding which will enhance the problem solving and decision making quality.
Illumina Inc., Qiagen NV, Thermo Fisher Scientific Inc., DNAnexus, BioMax, Perkin Elmer and others are some of the role playing companies.
The large number of market players operating in the global bioinformatics industry is investing in research and development projects.
They are also looking forward towards technological advances for increasing applications in biosciences and integrated information technology.Bioinformatics Marketreport is segmented as below:The Global Bioinformatics Marketstudy across various end user industries is incorporated in the report.A.
Synthetic Biology Markethttps://industryarc.com/Report/15142/synthetic-biology-market.htmlWhat can you expect from the report?The Bioinformatics MarketReport is Prepared with the Main Agenda to Cover the following 20 points:1.
